1. The Concept of Clinically Meaningful Difference in Health-Related Quality-of-Life Research

   • Ron D. Hays
   • J. Michael Woolley

   Current Opinion 23 December 2012 Pages: 419 - 423

2. HIV-1 Drug Resistance Genotyping

   • Carine Chaix-Couturier
   • Christopher Holtzer
   • John Stansell

   Review Article 23 December 2012 Pages: 425 - 433

   

3. Health-Related Quality-of-Life Measurement in Hypertension

   • Isabelle Côté
   • Jean-Pierre Grégoire
   • Jocelyne Moisan

   Review Article 23 December 2012 Pages: 435 - 450

   

4. Cost Analysis of an Adult Outpatient Parenteral Antibiotic Therapy (OPAT) Programme

   • Amy O. Wai
   • Luciana Frighetto
   • Peter J. Jewesson

   Original Research Article 23 December 2012 Pages: 451 - 457

   

5. Economic Impact of Increased Clinical Intervention Rates in Community Pharmacy

   • Shalom I. Benrimoj
   • Jane H. Langford
   • Matthew Dobson

   Original Research Article 23 December 2012 Pages: 459 - 468

   

6. Cost-Effectiveness Analysis of Topical Calcipotriol versus Short- Contact Dithranol

   • Darren M. Ashcroft
   • Alain Li Wan Po
   • Christopher E. M. Griffiths

   Original Research Article 23 December 2012 Pages: 469 - 476

   

7. Economic Impact of Tibolone Compared with Continuous-Combined Hormone Replacement Therapy

   • Jonathan M. Plumb
   • Julian F. Guest

   Original Research Article 23 December 2012 Pages: 477 - 486

   

8. Inhaled Fluticasone Propionate

   • Harriet M. Lamb
   • Christine R. Culy
   • Diana Faulds

   Adis Pharmacoeconomic Drug Evaluation 23 December 2012 Pages: 487 - 510

   

9. Economic Analysis of Long Term Reversible Contraceptives

   • Pekka Rissanen

   Correspondence 23 December 2012 Pages: 511 - 511

10. Economic Analysis of Long Term Reversible Contraceptives

    • Ceri J. Phillips

    Correspondence 23 December 2012 Pages: 511 - 512